Hi, help us enhance your experience
Hi, help us enhance your experience
Hi, help us enhance your experience
878 Views
Dr Narayanappa, Mysuru 15 January 2018
Age | First-line | Second-line | Suspected staph |
3 months-5 years | Amoxycillin/Cotrimoxazole | Co-amoxiclav/Cefuroxime/Cefpodoxime | Ampicillin-Cloxacillin/Cefuroxime/Co-amoxiclav |
5 years + | Amoxycillin | Macrolide/Co-amoxiclav/Cefpodoxime | Ampicillin-Cloxacillin/Cefuroxime/Co-amoxiclav |
Age | First-line | Second-line | Suspected staph |
0-3 months | Cefotaxime/Ceftriaxone + Aminoglycoside | Co-amoxyclav + Aminoglycoside | Cefotaxime/Ceftriaxone ± Vancomycin/Linezolid |
3 months-5 years | Ampicillin/Co-amoxyclav/Cefuroxime | Co-amoxiclav/ Cefotaxime/Ceftriaxone | Cefotaxime/Ceftriaxone + Cloxacillin ± Vancomycin/Linezolid |
5 years + | Ampicillin/Co-amoxiclav + Macrolides | Co-amoxiclav/Cefotaxime/Ceftriaxone + Macrolides | Cefotaxime/Ceftriaxone + Cloxacillin ± Vancomycin/Linezolid |
{{Article_Title}}
{{Article_Author}}
{{Article_Title}}
{{Article_Author}}